KalphaTech

KalphaTech explores 10x more experimental conditions with 10x less sample quantity while being 10x faster than current industrial standards. Our ExsolidusTM platform, designed for early stages in the drug development journey, offers unparalleled solid-state characterisation with as little as 100 mg of your sample. Built on top of our proprietary patent-pending PXRD 2.0 Analytics, we can achieve a synchrotron-level quality for structural analysis on regular laboratory XRD machines. Our AI analytics enables us to perform thousands of screening XRD experiments per day, achieving unmatched ultra-high-throughput methodology. From drug development, materials discovery, physical and chemical property optimisation, to the fastest quantitative cement analysis - let us know where we can help you innovate.